Article

The ECAT ART Scanner for Positron Emission Tomography. 1. Improvements in Performance Characteristics.

PET Facility, Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA
Clinical Positron Imaging 02/1999; 2(1):5-15. DOI: 10.1016/S1095-0397(98)00057-0
Source: PubMed

ABSTRACT The widespread use of positron emission tomography (PET) has been to some extent limited by the cost and complexity of PET instrumentation. Recognition of the wider applicability of clinical PET imaging is reflected in the ECAT ART design, a low cost PET scanner targeted for clinical applications, particularly in oncology. The ART comprises two asymmetrically opposed arrays of BGO block detectors. Each array consists of 88 (transaxial) by 24 (axial) crystals, and the arrays rotate continuously at 30 rpm to acquire a full 3D projection data set. Sensitivity and count rate limitations are key performance parameters for any imaging device. This paper reports on improved performance characteristics of the ART, achieved by operating the scanner with a decreased block integration time, reduced coincidence time window, and collimated singles transmission sources. Compared to the standard ART configuration, these modifications result in both improved count rate performance and higher quality transmission scans.

0 Bookmarks
 · 
93 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nuclear Medicine is the specialty of medical imaging, which utilizes a variety of radionuclides incorporated into specific compounds for diagnostic imaging and therapeutic applications. During recent years, research efforts in this discipline have concentrated on the decay characteristics of particular radionuclides and the design of unique radiolabeled tracers necessary to achieve time-dependent molecular images. Various oncology applications have utilized specific PET and SPECT radiopharmaceuticals, which have allowed an extension from functional process imaging in tissue to pathologic processes and nuclide directed treatments. One of the most widely recognized advantages of positron emission tomography (PET) is its use of the attractive, positron-emitting biologic radiotracers that mimic natural substrates. However, a major disadvantage is that these substances are relatively short-lived and unable to be transported great distances. At this time, economic considerations and regulatory guidelines associated with the creation of a PET facility, as well as the operational costs of maintaining both the facility and the necessary procedural documentation, continue to create interesting strategic dilemmas. This commentary will focus on the current approach and anticipated impact of pending regulations, which relate to the manufacture and formulation of a variety of PET radiopharmaceuticals used in clinical research and patient management at Memorial Hospital.
    Annals of Nuclear Medicine 01/2000; 13(6):379-82. · 1.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Software-based image fusion is used routinely for the alignment of functional and anatomical images of the brain. For other parts of the body, image registration is more problematic owing to differences in patient positioning, scanner bed profiles and the involuntary movement of internal organs. An alternative to the software approach is a scanner that acquires both function and anatomy during a single imaging session: a fusion of the technologies rather than a fusion of the images post hoc. Consequently, we designed and built a prototype combined PET and CT scanner comprising a clinical CT and a clinical PET scanner mounted together in a single gantry. Over 300 cancer patients have been imaged in the scanner to establish the clinical value of the combined PET/CT approach. The CT images were used to provide essentially noiseless attenuation correction factors for the PET data. The widespread interest created by the patient studies acquired with the prototype PET/CT stimulated commercial activity and several major vendors of medical imaging equipment now offer combined PET/CT designs. This paper reviews the development of the combined PET/CT scanner, and illustrates the clinical aspects with some typical studies in cancer patients. The potential impact on medical practice of the commercial availability of PET/CT scanner technology at affordable cost is assessed.
    British Journal of Radiology 12/2002; 75 Spec No:S24-30. · 1.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: (R)-[(11)C]rolipram and (S)-[(11)C]rolipram have been proposed to investigate phosphodiesterase-4 and, indirectly, cAMP-mediated signaling with PET. This study assessed binding of these tracers to phosphodiesterase-4 in canine myocardium. Seven dogs underwent (R)-[(11)C]rolipram and (S)-[(11)C]rolipram dynamic PET imaging at baseline and with co-injection of saturating doses of (R)-rolipram. Dual-input compartment models were applied to estimate the volumes of distribution (V(T)). The model comprising one compartment for unmetabolized tracer and one compartment for labeled metabolites provided excellent fits to data acquired with (S)-[(11)C]rolipram at baseline and with both enantiomers during co-injection scans. Use of two compartments for unmetabolized (R)-[(11)C]rolipram at baseline was warranted according to Akaike and Schwarz criteria. V(T) estimates obtained with these models were robust (CV ≤ 8.2%) and reproducible (CV ≤ 15%). An important fraction (~65%) of the V (T) of (R)-[(11)C]rolipram at baseline reflects specific binding. Thus, the latter may be a useful index of phosphodiesterase-4 levels in canine myocardium.
    Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging 03/2011; 14(2):225-36. · 2.47 Impact Factor